The hallmarks of cancer are determined by cancer-associated gene expression pattern that is determined by cancer-associated chromatin configuration (CACC). Using non-carcinogenic genotoxic drugs (NCGDs) to alter CACC could change cancer-associated gene expression pattern, which in turn, might cause disappearance of some or whole hallmarks of cancer and as a result, cancer cells could be killed by either apoptosis or immune destruction. Therefore, cancer could be prevented and treated by administration of NCGDs that can alter CACC in cancer cells.
Cite this paper
Li, G. (2021). A Novel Strategy for Preventing and Treating Cancer: Alteration of Cancer-Associated Chromatin Configuration. Open Access Library Journal, 8, e7347. doi: http://dx.doi.org/10.4236/oalib.1107347.
Corces, M.R. and Corces, V.G. (2016) The Three-Dimensional Cancer Genome. Current Opinion in Genetics & Development, 36, 1-7.
https://doi.org/10.1016/j.gde.2016.01.002
Feng, Y. and Pauklin, S. (2020) Revisiting 3D Chromatin Architecture in Cancer Development and Progression. Nucleic Acids Research, 48, 10632-10647.
https://doi.org/10.1093/nar/gkaa747
Li, G.D. (2019) Further Thoughts on Abnormal Chromatin Configuration and Oncogenesis. Open Access Library Journal, 6, e5185.
https://doi.org/10.4236/oalib.1105185
Li, G.D. (2020) Targeting Three-Dimensional Genome Architecture Might Be One of the Mechanisms of Chloroquine’s Diverse Therapeutic Actions. Open Access Library Journal, 7, e6340. http://doi.org/10.4236/oalib.1106340
Li, G.D. (2020) Non-Carcinogenic Genotoxic Drugs Could Be Used to Prevent and Treat COVID-19. Open Access Library Journal, 7, e6536.
https://doi.org/10.4236/oalib.1106536
Yan, M. and Liu, Q. (2016) Differentiation Therapy: A Promising Strategy for Cancer Treatment. Chinese Journal of Cancer, 35, Article No. 3.
https://doi.org/10.1186/s40880-015-0059-x
Alakhras, RS., Stephanou, G., Demopoulos, N.A. and Nikolaropoulos, S.S. (2011) Genotoxicity of All-Trans Retinoic Acid (ATRA) and Its Steroidal Analogue EA-4 in Human Lymphocytes and Mouse Cells in Vitro. Cancer Letters, 306, 15-26.
https://doi.org/10.1016/j.canlet.2011.02.010
Turkez. H., Arslan, M.E. and Ozdemir, O. (2017) Genotoxicity Testing: Progress and Prospects for the Next Decade. Expert Opinion on Drug Metabolism & Toxicology, 13, 1089-1098. https://doi.org/10.1080/17425255.2017.1375097
Butt, G., Farooqi, A.A., Adylova, A., Attar, R., Yilmaz, S., Konysbayevna, K.K., Sabitaliyevich, U.Y., Gasparri, M.L. and Xu, B. (2020) Vitamin C as an Anticancer Agent: Regulation of Signaling Pathways. Current Topics in Medicinal Chemistry, 20, 1868-1875. https://doi.org/10.2174/1568026620666200710102841
Song, Y., Zhong, X., Gao, P., Zhou, C., Shi, J., Wu Z., Guo, Z. and Wang, Z. (2020) Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review. Frontiers in Endocrinology, 11, Article No. 3. https://doi.org/10.3389/fendo.2020.00003
Bonovas, S., Filioussi, K. and Sitaras, N.M. (2006) Paracetamol Use and Risk of Ovarian Cancer: A Meta-Analysis. British Journal of Clinical Pharmacology, 62, 113-121. https://doi.org/10.1111/j.1365-2125.2005.02526.x
Zhang, Y., Liao, Z., Zhang, L.J. and Xiao, H.T. (2015) The Utility of Chloroquine in Cancer Therapy. Current Medical Research and Opinion, 31, 1009-1013.
https://doi.org/10.1185/03007995.2015.1025731
Vancura, A., Bu, P., Bhagwat, M., Zeng, J. and Vancurova, I. (2018) Metformin as an Anticancer Agent. Trends in Pharmacological Sciences, 39, 867-878.
https://doi.org/10.1016/j.tips.2018.07.006
Tomeh, M.A., Hadianamrei, R. and Zhao, X. (2019) A Review of Curcumin and Its Derivatives as Anticancer Agents. International Journal of Molecular Sciences, 20, Article No. 1033. https://doi.org/10.3390/ijms20051033
Wang, Y., Liu, Y., Du, X., Ma, H. and Yao, J. (2020) The Anti-Cancer Mechanisms of Berberine: A Review. Cancer Management and Research, 12, 695-702.
https://doi.org/10.2147/CMAR.S242329
